Searchable abstracts of presentations at key conferences in endocrinology

ea0063p810 | Thyroid 2 | ECE2019

Outcomes of treatment for severe and active Graves’ ophthalmopathy

Luchtenberg Maria Florencia , Capel Ismael , Visa Josep , Escamilla Yolanda , Subias David , Gimenez-Palop Olga , Albert Lara , Mazarico Isabel , Rigla Mercedes

Introduction: Graves’ ophthalmopathy (GO) is an orbital autoimmune disorder closely linked to thyroid autoimmunity, mainly Graves’ disease. After an initial progressive inflammatory period (active phase), GO stabilizes and eventually subsides (inactive phase). Treatment should rely on a thorough assessment of the activity and severity of GO and its impact on the patient’s quality of life. Patients with active, mild disease generally benefit from local therapies ...